Literature DB >> 1800813

Morphological changes of blood vessels in the brain with Alzheimer's disease.

T Hashimura1, T Kimura, T Miyakawa.   

Abstract

Morphological changes of microvessels in the cerebral cortices of Alzheimer's disease and control brains were examined. From several parts of the brains, all of the vessels in blocks of tissues were isolated with ultrasound treatment and mesh filtration, and were observed by light microscopy. The results obtained were as follows: There was no difference between the relatively large arteries of the brains with Alzheimer's disease and the control brains. However, in the Alzheimer's brain irregular shapes of blood vessels and degenerated smooth muscle cells of a single layer were observed in the terminal arterioles. In the capillaries, focal constrictions and irregular shapes were observed. In addition to these changes, the nuclei of endothelial cells were irregular and unclear. These findings seem to indicate that the degeneration of microvessels in the brain of Alzheimer's disease might have occurred at the terminal arterioles and the capillaries.

Entities:  

Mesh:

Year:  1991        PMID: 1800813     DOI: 10.1111/j.1440-1819.1991.tb01187.x

Source DB:  PubMed          Journal:  Jpn J Psychiatry Neurol        ISSN: 0912-2036


  11 in total

1.  Impaired orthotopic glioma growth and vascularization in transgenic mouse models of Alzheimer's disease.

Authors:  Daniel Paris; Nowel Ganey; Magdalena Banasiak; Vincent Laporte; Nikunj Patel; Myles Mullan; Susan F Murphy; Gi-Taek Yee; Corbin Bachmeier; Christopher Ganey; David Beaulieu-Abdelahad; Venkatarajan S Mathura; Steven Brem; Michael Mullan
Journal:  J Neurosci       Date:  2010-08-25       Impact factor: 6.167

Review 2.  Neural architecture: from cells to circuits.

Authors:  Sarah E V Richards; Stephen D Van Hooser
Journal:  J Neurophysiol       Date:  2018-05-16       Impact factor: 2.714

Review 3.  Cerebrovascular reactivity to carbon dioxide in Alzheimer's disease.

Authors:  Lidia Glodzik; Catherine Randall; Henry Rusinek; Mony J de Leon
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

4.  Peripheral Inflammation, Apolipoprotein E4, and Amyloid-β Interact to Induce Cognitive and Cerebrovascular Dysfunction.

Authors:  Felecia M Marottoli; Yuriko Katsumata; Kevin P Koster; Riya Thomas; David W Fardo; Leon M Tai
Journal:  ASN Neuro       Date:  2017 Jul-Aug       Impact factor: 4.146

5.  Cerebrovascular-Reactivity Mapping Using MRI: Considerations for Alzheimer's Disease.

Authors:  J J Chen
Journal:  Front Aging Neurosci       Date:  2018-06-05       Impact factor: 5.750

Review 6.  Targeting pericytes for therapeutic approaches to neurological disorders.

Authors:  Jinping Cheng; Nils Korte; Ross Nortley; Huma Sethi; Yamei Tang; David Attwell
Journal:  Acta Neuropathol       Date:  2018-08-10       Impact factor: 17.088

Review 7.  Emerging links between cerebrovascular and neurodegenerative diseases-a special role for pericytes.

Authors:  Urban Lendahl; Per Nilsson; Christer Betsholtz
Journal:  EMBO Rep       Date:  2019-10-16       Impact factor: 8.807

Review 8.  Impact of Tau on Neurovascular Pathology in Alzheimer's Disease.

Authors:  Elisa Canepa; Silvia Fossati
Journal:  Front Neurol       Date:  2021-01-07       Impact factor: 4.003

9.  Molecular Pathobiology of the Cerebrovasculature in Aging and in Alzheimers Disease Cases With Cerebral Amyloid Angiopathy.

Authors:  Joseph O Ojo; Jon M Reed; Gogce Crynen; Prashanthi Vallabhaneni; James Evans; Benjamin Shackleton; Maximillian Eisenbaum; Charis Ringland; Anastasia Edsell; Michael Mullan; Fiona Crawford; Corbin Bachmeier
Journal:  Front Aging Neurosci       Date:  2021-05-17       Impact factor: 5.750

10.  APOE genotype dependent molecular abnormalities in the cerebrovasculature of Alzheimer's disease and age-matched non-demented brains.

Authors:  Joseph O Ojo; Jon M Reed; Gogce Crynen; Prashanthi Vallabhaneni; James Evans; Benjamin Shackleton; Maximillian Eisenbaum; Charis Ringland; Anastasia Edsell; Michael Mullan; Fiona Crawford; Corbin Bachmeier
Journal:  Mol Brain       Date:  2021-07-08       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.